COMPASS Pathways announces further positive results from groundbreaking phase IIb trial of investigational COMP360… Dec 1, 2021
First-ever Human Data on SSRI – Psilocybin Interactive Effects Published by MindMed and Liechti Lab Nov 30, 2021
Pharmadrug Announces Successful Completion of Pre-IND Meeting with FDA Regarding Proposed Development of Its… Nov 30, 2021
MindMed and Liechti Lab publish first human data on the interacting effects of an SSRI and psilocybin Nov 30, 2021
Cybin Announces FDA Investigational New Drug and Institutional Review Board Approvals for a Co-Funded Phase 2 Clinical… Nov 30, 2021
PharmaTher Granted New Japanese Patent for KETABET™ (Ketamine Combination Formulation), Strengthening Global Patent… Nov 30, 2021
